SCHEMBL7918401

SCHEMBL7918401

CC(=O)Nc1cccc2c1CCC1(CNC(C)=N1)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ADRA2A P08913 1/20 0.35
HPGD P15428 2/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
GAA P10253 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LMNA P02545 1/20 0.34
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
TIPARP Q7Z3E1 1/20 0.34
CASP3 P42574 1/20 0.33
CHEK1 O14757 1/20 0.33
SLC18A3 Q16572 1/20 0.33
PARP14 Q460N5 1/20 0.33
CCNE2 O96020 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7922107 0.88 NPC1 (0.41) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL7913137 0.83 NPC1 (0.37) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL7920063 0.81 NPC1 (0.43) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL7916903 0.76 NPC1 (0.39) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL7919151 0.73 NPC1 (0.40) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL12203536 0.73 ALDH1A1 (0.35) NPC1ALDH1A1ADRA2AKMT2ACDK2
SCHEMBL12203540 0.72 PIM1 (0.32)
SCHEMBL7924554 0.71 CYP11B1 (0.33) ALDH1A1KMT2A
SCHEMBL7916694 0.71 CYP11B1 (0.33) ALDH1A1KMT2A
SCHEMBL7918188 0.70 HTR1A (0.42) ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010042475-A1 SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS SCHERING CORPORATION (US) 2010-04-15 WO disclosed